On the one hand, the loss of Gal-3 appears to be associated with the progression of PCa, as it occurs in hormone-refractory disease relative to hormone-sensitive PCa, and correlates with tumour aggressiveness (GS and disease stage) [25,32,37]. The gene discussed is LGALS3; the disease is neoplasm.